Acute kidney injury: A conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules

Pediatric Nephrology

Volumn 27, Issue 10, 2012, Pages 1847-1854

  Lu, Christopher Y ^a   Winterberg, Pamela D ^a   Chen, Jianlin ^a   Hartono, John R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Damage associated molecular patterns; Innate immunity; Ischemic acute kidney injury; Toll like receptor; Transplant rejection

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ENDOTHELIUM; HUMAN; IMMUNE RESPONSE; KIDNEY TUBULE; LEUKOCYTE; MALADJUSTMENT; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ACUTE KIDNEY INJURY; ANIMALS; ENDOTHELIAL CELLS; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KIDNEY TUBULES; LEUKOCYTES; LIGANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84867032429     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2029-0     Document Type: Review

References (96)

1. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961-973
2. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK (2010) Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298:F1078
3. Molitoris BA (2003) Transitioning to therapy in ischemic acute renal failure. J Am SocNephrol 14:265-267
4. Legrand M, Mik EG, Johannes T, Payen D, Ince C (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 14:502-516
5. Feldkamp T, Park JS, Pasupulati R, Amora D, Roeser NF, Venkatachalam MA, Weinberg JM (2009) Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 297:F1632-F1646
6. Brooks C, Wei Q, Cho SG, Dong Z (2009) Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119:1275-1285
7. Basile DP, Friedrich JL, Spahic J, Knipe NL, Mang HE, Leonard EC, Ashtiyani SC, Bacallao RL, Molitoris BA, Sutton TA (2010) Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 300:F721-F733
8. Goligorsky MS, Patschan D, Kuo MC (2009) Weibel-Palade bodies-sentinels of acute stress. Nat Rev Nephrol 5:423-426
9. Schrier RW, Wang W, Poole B, Mitra A (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114:5-14
10. Sutton TA, Fisher CJ, Molitoris BA (2002) Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62:1539-1549
11. Bonventre JV, Zuk A (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66:480-485
12. Jang HR, Rabb H (2009) The innate immune response in ischemic acute kidney injury. Clin Immunol 130:41-50
13. Kinsey GR, Li L, Okusa MD (2008) Inflammation in acute kidney injury. Nephron Exp Nephrol 109:e102-e107
14. Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfiled SM (1997) The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29:79-81
15. Nadeau KC, Azuma H, Tilney NL (1996) Cytokines in the pathophysiology of acute and chronic allograft rejection. TransplantRev 10:99-107
16. Land W, Messmer K (1996) The impact of ischemia/ reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. TransplantRev 10:108-127
17. Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR (1999) Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 55:2157-2168
18. Boros P, Bromberg JS (2006) New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6:652-658
19. Renner B, Coleman K, Goldberg R, Amura C, Holland-Neidermyer A, Pierce K, Orth HN, Molina H, Ferreira VP, Cortes C, Pangburn MK, Holers VM, Thurman JM (2010) The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. J Immunol 185:3086-3094
20. Bao L, Wang Y, Chang A, Minto AW, Zhou J, Kang H, Haas M, Quigg RJ (2007) Unrestricted C3 activation occurs in Crrydeficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol 18:811-822
21. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD (2010) IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120:331-342
22. Linfert D, Chowdhry T, Rabb H (2009) Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 23:1-10
23. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, da Silva CJ, Ulevitch RJ, Hoffman HM, McKay DB (2010) An Inflammasome-Independent Role for Epithelial-Expressed Nlrp3 in Renal Ischemia-Reperfusion Injury. J Immunol 185:6277-6285
24. Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva CJ, Ulevitch RJ, McKay DB (2010) Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 184:2297-2304
25. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY (2011) Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 79:288-299
26. Wang Y, John R, Chen J, Richardson JA, Shelton JM, Bennett M, Zhou XJ, Nagami GT, Zhang Y, Wu QQ, Lu CY (2009) IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol 20:1544-1555
27. Lu CY, Hartono J, Senitko M, Chen J (2007) The inflammatory response to ischemic acute kidney injury: a result of the 'right stuff' in the 'wrong place'? Curr Opin Nephrol Hypertens 16:83-89
28. Matzinger P (2007) Friendly and dangerous signals: is the tissue in control? Nat Immunol 8:11-13
29. Oppenheim JJ, Tewary P, de la Rosa G, Yang D (2007) Alarmins initiate host defense. Adv Exp Med Biol 601:185-194
30. Rock KL, Latz E, Ontiveros F, Kono H (2010) The sterile inflammatory response. Annu Rev Immunol 28:321-342
31. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR (2006) Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430-437
32. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. AnnuRevImmunol 21:335-76.:335-376.
33. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178:6252-6258
34. Jiang D, Liang J, Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435-461
35. Rosin DL, Okusa MD (2011) Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22:416-425
36. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, Tracey KJ (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 107:11942-11947
37. Li J, Gong Q, Zhong S, Wang L, Guo H, Xiang Y, Ichim TE, Wang C-Y, Chen S, Gong F, Chen G (2010) Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant:gfq466.
38. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117:2847-2859
39. Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Kramer BK, Colvin RB, Heeger PS, Murphy BT, Schroppel B (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106:3390-3395
40. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ (2010) HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. J Am Soc Nephrol 21:1878-1890
41. Andersson U, Tracey KJ (2011) HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection. Annu Rev Immunol 29:139-162
42. Chen J, Hartono JR, John R, Bennett M, Zhou XJ, Wang Y, Wu Q, Winterberg PD, Nagami GT, Lu CY (2011) Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 80:504-515
43. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, Leemans JC (2008) Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/ reperfusion injury. PLoS ONE 3:e3596
44. Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, Roos M, Kirschning C, Heemann U, Lutz J (2010) Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 25:853-860
45. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MF, Fisher EM (2000) Genealogies of mouse inbred strains. Nat Genet 24:23-25
46. Wade CM, Kulbokas EJ III, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, Daly MJ (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420:574-578
47. Petkov PM, Ding Y, Cassell MA, Zhang W, Wagner G, Sargent EE, Asquith S, Crew V, Johnson KA, Robinson P, Scott VE, Wiles MV (2004) An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 14:1806-1811
48. Nadeau JH (2001) Modifier genes in mice and humans. Nat Rev Genet 2:165-174
49. Rivera J, Tessarollo L (2008) Genetic background and the dilemma of translating mouse studies to humans. Immunity 28:1-4
50. Eisener-Dorman AF, Lawrence DA, Bolivar VJ (2009) Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 23:318-324
51. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67:2454-2461
52. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van't Veer C (2002) In vivo expression of Tolllike receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286-1293
53. Kashgarian M (1999) Acute tubular necrosis an ischemic renal injury. In: Jennette JC, Olsen JC, Schwartz MM, Silva FG (eds) Heptinstall's Pathology of the Kidney. Lippincott - Raven, Philadelphia New York, pp 863-889
54. Lieberthal W, Nigam SK, Bonventre JV, Brezis M, Siegel N, Rosen S, Portilla D, Venkatachalam M (1998) Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 275:F623-F631
55. Lucke B (1946) Lower nephron nephrosis. Mil Surg 99:371-396
56. Oliver J, Mac DM, Tracy A (1951) The pathogenesis of acute renal failure associated with traumatic and toxic injury; renal ischemia, nephrotoxic damage and the ischemic episode. J Clin Invest 30:1307-1439
57. Solez K (1983) Pathogenesis of acute renal failure. Int Rev Exp Pathol 24:277-333
58. Brezis M, Rosen S, Silva P, Epstein FH (1984) Renal ischemia: a new perspective. Kidney Int 26:375-383
59. De Greef KE, Ysebaert DK, Persy V, Vercauteren SR, De Broe ME (2003) ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF. Kidney Int 63:1697-1707
60. De Greef KE, Ysebaert DK, Dauwe SE, Persy VP, Vercauteren S, Mey D, De Broe ME (2001) Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 60:1415-1427
61. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-ramos JC, Bonventre JV (1996) Intercellular Pediatr Nephrol (2012) 27:1847-1854 1853 adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056-1063
62. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV (1995) Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816
63. Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre JV, Ramirez G (1994) Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physio 267: F1052-F1058
64. Kiew LV, Munavvar AS, Law CH, Azizan AN, Nazarina AR, Sidik K, Johns EJ (2004) Effect of antisense oligodeoxynucleotides for ICAM-1 on renal ischaemia-reperfusion injury in the anaesthetised rat. J Physiol 557:981-989
65. Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, Gross V, Lust FC (1996) Antisense oligonucleotides for ICAM 1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50:473-480
66. Dagher PC, Basile DP (2008) An expanding role of Toll-like receptors in sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 294:F1048-F1049
67. Rumbaut RE, Bellera RV, Randhawa JK, Shrimpton CN, Dasgupta SK, Dong JF, Burns AR (2006) Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism. Am J Physiol Heart Circ Physiol 290:H1671-H1679
68. Andonegui G, Zhou H, Bullard D, Kelly MM, Mullaly SC, McDonald B, Long EM, Robbins SM, Kubes P (2009) Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest 119:1921-1930
69. Li C, Jackson RM (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241
70. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95:11715-11720
71. Nath KA, Norby SM (2000) Reactive oxygen species and acute renal failure. Am J Med 109:665-678
72. Sutton TA (2009) Alteration of microvascular permeability in acute kidney injury. Microvasc Res 77:4-7
73. Basile DP (2007) The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 72:151-156
74. Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, Issekutz A, Kasiske BL, Keane WF, Rabb H (2001) Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 60:2205-2214
75. Friedewald JJ, Rabb H (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int 66:486-491
76. Li L, Huang L, Sung SS, Lobo PI, Brown MG, Gregg RK, Engelhard VH, Okusa MD (2007) NKT Cell Activation Mediates Neutrophil IFN-{gamma} Production and Renal Ischemia- Reperfusion Injury. J Immunol 178:5899-5911
77. Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227:248-263
78. Gonzalez-Navajas JM, Fine S, Law J, Datta SK, Nguyen KP, Yu M, Corr M, Katakura K, Eckman L, Lee J, Raz E (2010) TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest 120:570-581
79. Fan J, Frey RS, Malik AB (2003) TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clinl Invest 112:1234-1243
80. Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K (2007) Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88- mediated pathways. Int Immunol 19:311-320
81. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR (2005) Hepatic ischemia/ reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175:7661-7668
82. Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, Thiemermann C (2005) Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312:1170-1178
83. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY (2005) Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16:3315-3325
84. Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L, Musco G, Bianchi ME (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14:431-441
85. Girard JP (2007) A direct inhibitor of HMGB1 cytokine. Chem Biol 14:345-347
86. Kim BS, Lim SW, Li C, Kim JS, Sun BK, Ahn KO, Han SW, Kim J, Yang CW (2005) Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79:1370-1377
87. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H, Verrier ED (2006) Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemiareperfusion injury. Circulation 114:I270-274
88. Liu M, Gu M, Xu D, Lv Q, Zhang W, Wu Y (2010) Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemiareperfusion injury. Transplant Proc 42:1539-1544
89. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, Xu R, Sotolongo J, Espana C, Zaias J, Elson G, Mayer L, Kosco- Vilbois M, Abreu MT (2009) A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296:G1167-G1179
90. Fort MM, Mozaffarian A, Stover AG, Correia Jda S, Johnson DA, Crane RT, Ulevitch RJ, Persing DH, Bielefeldt-Ohmann H, Probst P, Jeffery E, Fling SP, Hershberg RM (2005) A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 174:6416-6423
91. Barochia A, Solomon S, Cui X, Natanson C, Eichacker PQ (2011) Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Expert Opin Drug Metab Toxicol 7:479-494
92. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351-12356
93. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517-524
94. Zhu S, Li W, Ward MF, Sama AE, Wang H (2010) High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 9:60-72
95. Chung KY, Park JJ, Kim YS (2008) The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate. Transplant Proc 40:2136-2138
96. Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC (2011) Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol 162:1498-1508